Isoproterenol
Active ingredient · 3 therapeutic classes
Sold as ISOPRENALINE HYDROCHLORIDE
- Drug class
- Adrenergic and Dopaminergic Agents
- Availability
- Prescription only
- Routes
- Intravenous, Intracardiac, Intramuscular, Subcutaneous
- Markets covered
- 3
- Products on record
- 15
Overview
Isoproterenol is an active pharmaceutical ingredient in the Adrenergic and Dopaminergic Agents group (C01CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 7 | April 10, 2026 |
| US United States | FDA | 4 | March 17, 2026 |
| CA Canada | Health Canada | 4 | March 22, 2025 |
GBUnited Kingdom· MHRA
7 products
Uses
Short-term treatment of permanent bradycardia due to atrio-ventricular block while pending a pacemaker or when a pacemaker is contraindicated. Short-term treatment of Adams-Stokes syndrome. National and international recommendations and guidelines on the appropriate use of isoprenaline should be followed.
How to take
USUnited States· FDA
4 products
Uses
1 INDICATIONS AND USAGE Isoproterenol hydrochloride injection is indicated: To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output For bronchospasm occurring during anesthesia Isoproterenol hydrochloride injection is a beta-adrenergic agonist indicated: To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output ( 1 ) For treatment of bronchospasm occurring during anesthesia ( 1 )
How to take
CACanada· Health Canada
4 products
4 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Isoproterenol. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 328. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL392800033 · revised October 31, 2025
- [2]FDA DailyMed · 046f2941-3bc0-47… · revised June 27, 2024 [PDF]
- [3]Health Canada (DPD) · 00897639 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.